A study of the prevalence of systemic sclerosis in northeast England

被引:89
作者
Allcock, RJ
Forrest, I
Corris, PA
Crook, PR
Griffiths, ID
机构
[1] Freeman Rd Hosp, Dept Resp Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Wamsbeck Gen Hosp, Dept Rheumatol, Ashington NE63 9JJ, Northd, England
[3] Freeman Rd Hosp, Dept Rheumatol, Newcastle Upon Tyne, Tyne & Wear, England
关键词
systemic sclerosis; prevalence; scleroderma; CREST;
D O I
10.1093/rheumatology/keh124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We aimed to obtain an estimate of the prevalence and demographics of systemic sclerosis (SSc) and its subtypes at the turn of the millennium. Methods. Case finding from multiple sources from a defined geographical area. Diagnosis confirmed by clinical examination. Results. The crude prevalence of SSc in northeast England was 8.8 (95% CI: 6.8-10.8) per 100 000. The prevalence when adjusted for the entire UK is 8.2 (95% CI: 6.2-9.8) per 100 000. The ratio of women to men was 5.2:1. The median age of patients was 57.1 yr. The ratio of limited cutaneous SSc to diffuse cutaneous SSc was 4.7:1. Limited cutaneous SSc is associated with the presence of anticentromere antibodies; diffuse cutaneous SSc is associated with anti-Scl 70 antibodies, but either antibody was found in either form of SSc. Conclusions. SSc appears to be more common in northeast England than was found in the West Midlands in 1986. This may reflect changes in the diagnostic definition of SSc.
引用
收藏
页码:596 / 602
页数:7
相关论文
共 31 条
  • [1] ALLCOCK R, 2001, ARTHRITIS RHEUM
  • [2] PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    不详
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (05): : 581 - 590
  • [3] Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma - Association with an Amerindian HLA haplotype
    Arnett, FC
    Howard, RF
    Tan, FM
    Moulds, JM
    Bias, WB
    Durban, E
    Cameron, HD
    Paxton, G
    Hodge, TJ
    Weathers, PE
    Reveille, JD
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (08): : 1362 - 1370
  • [4] ASBOEHANSEN G, 1985, SYSTEMIC SCLEROSIS S, P78
  • [5] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [6] BLACK CM, 1995, BRIT J RHEUMATOL, V34, P3
  • [7] A study of scleroderma in South Australia: Prevalence, subset characteristics and nailfold capillaroscopy
    Chandran, G
    Smith, M
    Ahern, MJ
    RobertsThomson, PJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (06): : 688 - 694
  • [8] Systemic sclerosis: Current pathogenetic concepts and future prospects for targeted therapy
    Denton, CP
    Black, CM
    Korn, JH
    deCrombrugghe, B
    [J]. LANCET, 1996, 347 (9013) : 1453 - 1458
  • [9] Systemic sclerosis prevalence and mortality in Sydney 1974-1988
    Englert, H
    Small-McMahon, J
    Davis, K
    O'Connor, H
    Chambers, P
    Brooks, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (01): : 42 - 50
  • [10] SYSTEMIC-SCLEROSIS IN ICELAND - A NATIONWIDE EPIDEMIOLOGIC-STUDY
    GEIRSSON, AJ
    STEINSSON, K
    GUDMUNDSSON, S
    SIGURDSSON, V
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (08) : 502 - 505